Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | -3.43% |
|
+2.74% | +108.33% |
Jul. 01 | Elutia Inc.(NasdaqCM:ELUT) dropped from Russell Microcap Growth Index | CI |
Jul. 01 | Elutia Inc.(NasdaqCM:ELUT) added to Russell Microcap Value Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+108.33% | 124M | D | ||
+5.37% | 97.06B | A- | ||
+6.18% | 41.54B | A- | ||
-10.06% | 33.89B | B- | ||
+81.18% | 29.78B | A | ||
-14.65% | 15.63B | C | ||
-3.28% | 13.66B | B- | ||
-12.70% | 11.43B | D+ | ||
+174.11% | 10.37B | D | ||
+5.09% | 9.14B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ELUT Stock
- Ratings Elutia Inc.